Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVenture Life Share News (VLG)

Share Price Information for Venture Life (VLG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 40.50
Bid: 40.00
Ask: 41.00
Change: 0.50 (1.25%)
Spread: 1.00 (2.50%)
Open: 40.00
High: 40.50
Low: 40.00
Prev. Close: 40.00
VLG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK TRADING UPDATE SUMMARY: Venture Life Sees Order Boost For Sanitiser

Tue, 09th Jun 2020 13:25

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

----------

Venture Life Group PLC - Berkshire-based self care products maker - Says order book "significantly ahead" of year prior. Reports solid demand for hand sanitiser gel product. Extends relationship with Alliance Pharma, becoming second manufacturer of Wiltshire-based pharmaceutical firm's Kelo-Cote scar gel products.

----------

Better Capital PCC Ltd - Guernsey-based investment company - To take write-down on valuation of investment in Everest, a British windows and home improvement firm. Better Capital's Fund II has invested GBP3.2 million into creation of Everest 2020, which bought assets of Everest Ltd, including its order pipeline. Pre-packaged administration deal rescued over 400 jobs at Everest and ensures existing orders can be completed.

----------

Plaza Centers NV - Netherlands-based property firm - Says buyer of company's stake in a shopping and entertainment centre in Belgrade will pay firm EUR830,000 to settle purchase. Plaza Centers to increase amount paid to bondholders to EUR500,000 from EUR250,000 at next payment date on July 1.

----------

Altyn PLC - gold miner in Kazakhstan - Says "positive momentum" continuing in second quarter with annualised monthly production run rate of 600,000 tonnes per year achieved in April and May. Altyn adds this represents 60% growth quarter-on-quarter. Altyn explains gold recovery grades also improved and beating budgeted targets. Seeing pick up in interest among investors, so far raised USD3.2 million out of USD10 million maximum in Astana Stock Exchange bond issue.

----------

Ormonde Mining PLC - Spain-focused natural resources - Cost-effective work programme at existing Spanish gold assets being advanced. Continuing to assess prospective projects, with 100 reviewed to date and a handful shortlisted "for further active consideration".

----------

Chaarat Gold Holdings Ltd - Gold miner in Armenia and Kyrgyz Republic - Targets 300,000 ounces per year production from 2026 at Kyzyltash deposit, Kyrgyz Republic. Lays out plans to get there, beginning with updated feasibility study in 2022, project financing in 2023 before construction follows in 2024 and 2025.

----------

Rockfire Resources PLC - Australia-focused gold and copper explorer - Reports results of 3D magnetic imagery at Plateau gold deposit in Lighthouse tenements, Australia. Probe confirms gold target beyond a depth of 600 metres. Field crew now in place to prepare for start of drilling.

----------

Star Phoenix Group Ltd - oilfield services firm in Trinidad - Yet to receive outstanding USD1.5 million payment from LandOcean Energy Services Co Ltd over sale of Range Resources Trinidad Ltd. Agreed deadline for payment was Monday and Star Phoenix has made "numerous attempts" to secure cash. Company now working with legal advisers.

----------

Destiny Pharma PLC - Brighton-based biotechnology firm - Awarded grant for research with Cardiff University to assess whether its DPD‑207, XF-70 and XF-73 drug compounds can treat fungal infections. Financial terms of partnership not disclosed.

----------

PureTech Health PLC - biotherapeutics firm based in Massachusetts - Reports "positive" data from founding company Vedanta Biosciences Inc's two Phase 1 studies of VE202 candidate for inflammatory bowel disease. Study shows VE202 was "safe and well-tolerated at all doses".

----------

Hutchison China Meditech Ltd - Hong Kong-based biopharmaceutical firm - Enters into agreement with Guangzhou government for planned return of Hutchison's remaining 34 years land-use rights of about 30,000 square meters of unused site. Hutchison will secure USD95 million for the return of the site.

----------

iEnergizer Ltd - Guernsey-based IT services firm - Reports strong performance in six months to March 31, its year end date. Says focus remained on high margin work and revenue set to be in line with market expectations but earnings before interest, taxes, depreciation and amortisation beating forecasts. Reaffirms commitment for progressive dividend policy.

----------

Redcentric PLC - London-based IT services provider - Extends loan facilities until June 30, 2022. Extended loan is a GBP17.5 million revolving credit facility provided by Barclays Bank PLC and National Westminster Bank PLC.

----------

By Eric Cunha; ericcunha@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
5 Jun 2015 15:03

AGM, EGM Calendar - Week Ahead

Read more
5 Jun 2015 05:21

AGM, EGM Calendar - Week Ahead

Read more
4 Jun 2015 15:22

AGM, EGM Calendar - Week Ahead

Read more
4 Jun 2015 05:11

AGM, EGM Calendar - Week Ahead

Read more
3 Jun 2015 15:03

AGM, EGM Calendar - Week Ahead

Read more
25 Mar 2015 14:11

Venture Life trims losses as ageing-population treatments gain traction

Full year results from consumer healthcare company Venture Life showed the first notable revenues for the company since it floated on AIM last March. Group revenues were transformed by the acquisition of Italian cosmetics manufacturer Biokosmes at the time of the flotation, rocketing to £7.2m from t

Read more
25 Mar 2015 11:32

Venture Life Loss Widens Slightly On Listing Costs

Read more
16 Mar 2015 11:08

Venture Life sells trademarks to unnamed customer

Venture Life, a company focused on developing products for the ageing population, on Monday sold some of its trademarks for one of its skincare products. The sale is expected to generate an average of at least €500,000 in additional revenues over the next five years, including through milestone paym

Read more
16 Mar 2015 07:35

Venture Life Agrees Sale Of Dermatology Product Trademarks

Read more
26 Jan 2015 08:27

UK MORNING BRIEFING: Irish Companies And Greek Elections In Focus

Read more
26 Jan 2015 07:43

Venture Life Secures 30-Year Distribution Deal With Chinese Retailer

Read more
13 Oct 2014 08:37

DIRECTOR DEALINGS: Venture Life Executive Buys 15,000 Shares

Read more
10 Oct 2014 09:09

DIRECTOR DEALINGS: Venture Life Director Buys 5,000 Shares

Read more
8 Oct 2014 07:54

DIRECTOR DEALINGS: Venture Life CEO Bolsters Shareholding

Read more
29 Sep 2014 11:53

Venture Life Expects Stronger Second Half As Interim Loss Widens

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.